Format

Send to

Choose Destination

Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species.

Author information

1
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri 63110.

Abstract

LY121019 and amphotericin B were equally active in vitro against most clinical isolates of Candida albicans and Candida tropicalis. Higher concentrations of LY121019 were required for inhibition of Candida glabrata. Other Candida species were inhibited by amphotericin B but not by LY121019.

PMID:
3132386
DOI:
10.1007/bf01962183
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center